RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
AVITA Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$13.14+0.10 (+0.77%)
Close on Oct 19, 2026
- Market cap
- $404.05M
- P/E (TTM)
- –
- Dividend yield
- –
AVITA Medical, Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| RPK | $35.80M | $17.50M | – | – | – | – | 50.0% | +104.6% |
| PermeaDerm | $6.00M | – | – | – | – | – | 8.4% | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| United States | $68.79M | $62.16M | $46.36M | $28.96M | $13.80M | $4.40M | 96.1% | +10.7% |
| Japan | $2.09M | $1.43M | $3.37M | – | – | – | 2.9% | +45.9% |
| United Kingdom | $486.00K | $196.00K | $141.00K | – | – | – | 0.7% | +148.0% |
| Australia | $200.00K | $312.00K | $222.00K | – | – | – | 0.3% | -35.9% |
| European Union | $49.00K | $155.00K | $51.00K | – | – | – | 0.1% | -68.4% |
From the segment and revenue-disaggregation notes of AVITA Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.